Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal ...
Share on Pinterest New colorectal cancer guidelines from the ACS highlight noninvasive screening methods. Image credit: Marco Govel/Stocksy The American Cancer Society (ACS) updated its colorectal ...
LR+ = positive likelihood ratio; LR– = negative likelihood ratio; PSA = prostate-specific antigen; PSE = EpiSwitch prostate screening. *—Binary PSA is defined as a simple test using a fixed cutoff ...
Freenome has partnered with Abbott to commercialize the test, which is expected to be available in the US this fall. The Food and Drug Administration (FDA) has approved Freenome’s SimpleScreen ™ CRC, ...
Approval of the SimpleScreen CRC test may increase earlier detection of colorectal cancer and improve patient outcomes. The FDA has approved SimpleScreen™ CRC, a blood-based screening option, for use ...
Colorectal cancer screening in America faces a critical paradox: while early detection dramatically improves survival rates, millions of eligible patients remain unscreened due to barriers ranging ...
Final analysis of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab for RAS wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13). Single-cycle neoadjuvant ...
The FDA approved the first at-home test for cervical cancer screening, developed by Teal Health. In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening ...
The American Cancer Society has added blood tests every three years as a new option for colorectal cancer screening, in addition to colonoscopy and stool tests. While invasive, colonoscopy remains the ...
Share on Pinterest Following FDA approval, could blood tests, such as SimpleScreen, help increase colorectal cancer screening uptake? adamkaz / Getty Images Despite colorectal cancer being one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results